Tag Archives: BIOTECH

Beware the Liability Gaps in Biotechnology M&As

Mike Yeager, Senior Underwriting Specialist, Chubb Mergers and acquisitions continue to be a source of growth for the biotechnology industry. Even the financial crisis has not significantly slowed this trend. In fact, a weakened global economy may have further fueled consolidation as biotechnology companies sought additional efficiencies in R&D, procurement or administration. Since many biotechnology companies have complex corporate structures—some with hundreds of subsidiaries—executives at acquiring companies recognize that along with the benefits of the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,

The Global Biotech Industry Comes to BIO

The world’s largest biotech hubs are busy planning their delegations’ visits to the BIO International Convention next month. The international program at the Convention will be one of the most robust to date, with International Case Studies, breakout sessions focused on globalization and Super Sessions focused on the emerging markets. BIOtechNOW is profiling a few of the top delegations to give you a preview*: Australia: Australia’s biotech sector, along with the broader Australian economy, performed Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

World Health Day: The Global Impact of Vaccines

Child Vaccination

As we celebrate World Health Day today, it is an opportunity to remember that vaccines represent one of the most important global health investments. The investment of time, money and dedication has brought enormous benefits to the world. According to the World Health Organization, immunizations save an estimated 2.5 million lives every year from diphtheria, tetanus, pertussis (whooping cough), and measles. Biotechnology is helping us improve existing vaccines and create new vaccines against infectious agents. Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Patent Reform Bill good for Biotech

Patent Reform Passes the Senate and Moves to the House   Posted by Roy Zwahlen, manager of intellectual property and technology transfer policy at BIO. On March 8th, the Senate approved the America Invents Act (S. 23) by an overwhelming vote of 95-5.  BIO supports this bipartisan, consensus-oriented bill, formerly known as the Patent Reform Act of 2011.  Once enacted into law, it will strengthen and improve our nation’s patent system, spurring innovation and job creation. Patents are often Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , ,

BIO’s Comments on proposed PTO Humanitarian Technologies and Licensing Through the Intellectual Property System

Here are the highlights from BIO’s recent submission on the proposed PTO “Request for Comments on Incentivizing Humanitarian Technologies and Licensing Through the Intellectual Property System.”   Background: 1.  “BIO’s members also understand that problems with access to medicines and other biotechnology products in the developing world have very little to do with the patent system, and are generally caused by other factors outside the control of individual stakeholders, such as lack of adequate local manufacturing, Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , ,